Literature DB >> 31910334

USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.

Sarah Kit Leng Lui, Prasanna Vasudevan Iyengar, Patrick Jaynes, Zul Fazreen Bin Adam Isa, Brendan Pang, Tuan Zea Tan, Pieter Johan Adam Eichhorn.   

Abstract

Entities:  

Year:  2019        PMID: 31910334      PMCID: PMC6944908          DOI: 10.15252/embr.201949618

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  3 in total

1.  USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.

Authors:  Thomas Mb Ware; Hong-Jian Zhu
Journal:  EMBO Rep       Date:  2019-12-20       Impact factor: 8.807

2.  Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.

Authors:  Sarah Kit Leng Lui; Prasanna Vasudevan Iyengar; Patrick Jaynes; Zul Fazreen Bin Adam Isa; Brendan Pang; Tuan Zea Tan; Pieter Johan Adam Eichhorn
Journal:  EMBO Rep       Date:  2019-12-20       Impact factor: 8.807

3.  USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.

Authors:  Sarah Kit Leng Lui; Prasanna Vasudevan Iyengar; Patrick Jaynes; Zul Fazreen Bin Adam Isa; Brendan Pang; Tuan Zea Tan; Pieter Johan Adam Eichhorn
Journal:  EMBO Rep       Date:  2017-04-05       Impact factor: 8.807

  3 in total
  2 in total

1.  Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms.

Authors:  Sifang Chen; Xi Chen; Zhangyu Li; Jianyao Mao; Weichao Jiang; Zhi Zhu; Yukui Li; Zhengye Jiang; Wenpeng Zhao; Guowei Tan; Zhanxiang Wang
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

Review 2.  The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target.

Authors:  Yun Yang; Wen-Long Ye; Ruo-Nan Zhang; Xiao-Shun He; Jing-Ru Wang; Yu-Xuan Liu; Yi Wang; Xue-Mei Yang; Yu-Juan Zhang; Wen-Juan Gan
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-22       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.